Cara Therapeutics | CARA - Ebitda





Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cassava Sciences USD -11.73M 33.44M 2025-09
Chugai Pharma JPY 169.01B 12.52B 2025-12
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 3.13B 1.17B 2025-12
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
J&J USD 9.52B 389M 2025-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Pacira USD 38.71M 10.65M 2025-12
Pfizer USD 6.08B 351M 2025-09
RedHill Biopharma USD 2.69M 108.46M 2023-06
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12